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The formation of Lewy bodies containing α-synuclein (α-syn), prominent loss of dopaminer-
gic neurons and dopamine (DA) deﬁciency in substantia nigra and striatum are histopatho-
logical and biochemical hallmarks of Parkinson’s disease (PD). Multiple lines of evidence
have indicated that a critical pathogenic factor causing PD is enhanced production of
reactive oxygen species (ROS), which reacts readily with polyunsaturated fatty acids to
cause lipid peroxidation (LPO). LPO products have been shown to facilitate assembly of
toxic α-syn oligomers in in vitro studies. Since DA is prone to autoxidation and cause ROS,
it has been suggested that interactions among DA, LPO, and α-syn play an important role
in neuronal loss in PD. However, the exact mechanism(s) remains unclear. We addressed
this issue using a neuronal cell model which inducibly expresses human wild-type α-syn by
the tetracycline off (Tet-Off) mechanism and stably expresses high levels of DA transporter.
Under retinoic acid elicited neuronal differentiation, cells with or without overexpressing
α-syn and with or without exposure to LPO inducer-arachidonic acid (AA), plus 0–500 μMof
DA were assessed for the levels of LPO, α-syn accumulation, cell viability, and autophagy.
AA exposure elicited similar LPO levels in cells with and without α-syn overexpression,
but signiﬁcantly enhanced the accumulation of α-syn oligomers and monomers only in
cultures with Tet-Off induction and decreased cell survival in a LPO-dependent manner.
Surprisingly, DA at low concentrations (<50 μM) protected cells from AA cytotoxicity and
α-syn accumulation. Such effectswere attributed to the ability of DA to preserve autophagic-
lysosomal function compromised by the AA exposure. At high concentrations (>100 μM),
DA exposure enhanced the toxic effects of AA. To our knowledge, this is the ﬁrst report
showing biphasic effects of DA on neuronal survival and α-syn accumulation.
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INTRODUCTION
Parkinson’s disease (PD) is characterized by accumulation of neu-
ronal inclusions containing α-synuclein (α-syn), degeneration
of dopaminergic neurons and deﬁciency of dopamine (DA) in
substantia nigra and striatum (Dauer and Przedborski, 2003).
Multiple lines of evidence have indicated that enhanced produc-
tion of reactive oxygen species (ROS) is a critical pathogenic factor
causing PD and that ROS can be generated via autoxidation of DA
(Jenner, 1991; Fahn and Cohen, 1992; Lotharius and Brundin,
2002; Tieu et al., 2003). ROS react readily with polyunsaturated
fatty acids (PUFAs), which are enriched in brain phospholipids
(Rapoport, 2008; Whelan, 2008), to generate peroxyl radical and
cause lipid peroxidation (LPO) via propagation and chain reac-
tion (Young and McEneny, 2001; Farooqui and Farooqui, 2011).
Such changes were shown to affect membrane properties and
result in neuronal dysfunction (Fernstrom, 1999; Farooqui and
Farooqui, 2011). It has been reported that presence of LPO prod-
ucts such as 4-hydroxynonenal, 4-oxo-2-nonenal or oxidized DA
can facilitate in vitro assembly of α-syn oligomers, but not that
of α-syn ﬁlaments (Li et al., 2004; Cappai et al., 2005; Qin et al.,
2007; Nasstrom et al., 2009). There are also evidences suggesting
a role of soluble oligomeric α-syn species in cytotoxicity (Winner
et al., 2011). These aforementioned ﬁndings along with informa-
tionderived frommanyother studies (Li et al., 1995;Hattoria et al.,
2009; Ruiperez et al., 2010) highlight a likely role of DA and LPO
in PD pathogenesis, hence it is important to investigate this issue
further.
In present study, we used a neuronal cellmodel of PD to investi-
gate interplays among DA, LPO, α-syn assembly and cell survival.
The model, referred to as 3D5/DAT, was generated from stable
transfection of 3D5 cells with humanDA transporter (DAT) genes
to increase DA uptake. Cells of 3D5 are derived from a human
neuroblastoma cell line inducible to express human wild-type α-
syn via the tetracycline off (Tet-Off) mechanism (Takahashi et al.,
2007). While the expression of α-syn is inducible, expression of
hDAT in 3D5/DATcells is not. It has previously beendemonstrated
that 3D5 cells upon Tet-Off induction and neuronal differentia-
tion via retinoic acid (RA) treatment are capable to accumulate
small amounts of α-syn oligomers and this process has very little
impacts on cell viability (Ko et al., 2008; Jiang et al., 2010). In cur-
rent cell-based studies, we focused on examining cultures with and
without (i) overexpressing α-syn, (ii) exposure to a LPO inducer
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arachidonic acid (AA), which is a major PUFA in the brain and
(iii) treatment with DA. These cells were assessed as to the extent
of LPO, α-syn accumulation, autophagy, and cell viability.
We found that induced α-syn expression had no effect on the
level of malondialdehyde (MDA), a product of LPO. However,
AA treatment affected MDA levels in a time-dependent man-
ner, regardless whether there was α-syn overexpression or not.
Exposure of 3D5/DAT cells with induced α-syn to AA caused
accumulation of α-syn oligomers and decrease of cell survival
when compared to non-induced controls. These changes were
accompanied with alteration of autophagy marker levels and
that of lysosomal membrane permeability. Such impacts could
be signiﬁcantly reduced by co-treatment of cultures with DA
at physiological concentration or rapamycin (Rapa) which is an
autophagy inducer. Importantly, the co-treatment prevented cells
from changes of lysosomal membrane permeability. Treatment of
cells to DA at higher concentrations led to cell death and enhanced
α-syn oligomer accumulation. To our knowledge, this is the ﬁrst
report showing biphasic effects of DA on neuronal cells.
MATERIALS AND METHODS
REAGENTS
Arachidonic acid, bovine serum albumin (BSA), DA, Rapa, wort-
mannin (WM), Trolox (TX), and Triacsin C (TC) were purchased
from Sigma. LysoTracker® Green DND-26 was from Invitrogen.
BSA stock solution was prepared in distilled water and stored
in 4oC. DA solution was prepared in distilled water freshly. All
other reagents were prepared in dimethyl sulfoxide (DMSO) for
stock solution and stored at −20oC according to product instruc-
tion. For treatment of cultures, the ﬁnal concentrations of AA,
Rapa, WM, TX, and TC in culture media are 250 μM, 20 nM,
150 nM, 100 μM, and 10 μM, respectively, and that of DA are
25–500 μM.
GENERATION OF A CELL MODEL WITH INDUCIBLE α-syn EXPRESSION
AND NON-INDUCIBLE EXPRESSION OF DOPAMINE TRANSPORTER
The cell model, referred to as 3D5/DAT, was generated via trans-
fection of 3D5 cells with pcDNA6-hDAT or empty vector using
Tfx-20 Reagent (Promega, Madison, WI, USA) and selected with
blasticidin (10 μg/mL) for 4 weeks. Cells of 3D5 were derived
from a human neuroblastoma BE2-M17D derived cell line and
have been characterized in previous studies (Ko et al., 2008; Jiang
et al., 2010). They are inducible to express human wild-type
α-syn by the Tet-Off mechanism in a time-dependent manner,
and responsive to RA treatment to display neuronal phenotypes
(Ko et al., 2008).
CELL CULTURES
Cultures of 3D5/DAT were maintained in Dulbecco’s Modiﬁed
Eagle Medium (DMEM)/10% fetal bovine serum with 2 μg/mL
Tet at 37◦C and 5% CO2. Those intended for biochemical analysis
were seeded at 1.5× 105 cells/well in 6-well plates. For spectropho-
tometric assay 3D5/DAT cells were seeded at 2 × 104 cells/well
in 24-well plates or 1 × 104 in 48-well plates (Bellco Glass Inc,
Vineland, NJ, USA), respectively. For cell differentiation and α-
syn induction, media were replaced next day with Tet deprived
Neurobasal medium (Invitrogen, Carlsbad, CA, USA), 2% B-27
supplement (antioxidant free, Invitrogen), 2 mM L-glutamine
(Sigma) and 20 μM RA (Sigma-Aldrich, St Louis, MO, USA).
For those without α-syn induction, medium was still supple-
mented with Tet. Cultures were subjected to different treatments
for durations to be described later.
WESTERN BLOT ANALYSIS
Cell cultures were harvested and centrifuged at 200 × g for
15 min. They were lysed in 2-(N-morpholino)ethanesulfonic
acid (MES) buffer (Jiang et al., 2010) supplemented with phos-
phatase inhibitors. The cell lysates were mixed with Tricine–
sodium dodecyl sulfate (SDS) sample buffer (Invitrogen) and
2% β-mercaptoethanol, boiled for 5 min and resolved by SDS-
polyacrylamide gel electrophoresis (SDS-PAGE) using 10–20%
Tris/Tricine gels (Bio-Rad, Hercules, CA, USA). Precision plus
protein standards (Bio-Rad) were included as references. Proteins
separated by SDS-PAGEwere transferred onto nitrocellulose paper
and processed for immunolabeling for proteins of interest. Mem-
branes were incubated with antibodies against: DAT (PRB-330P,
Covance), α-syn (Synuclein-1, BD Biosciences), LC3 (Novus Bio-
logicals), cleaved Caspase 3 (Cell Signaling), total mammalian
target of rapamycin (mTOR; Cell Signaling), Ser2448 phospho-
rylated mTOR (Cell Signaling), and glyceraldehyde 3-phosphate
dehydrogenase (GAPDH). Immunoreactivity was visualized with
enhanced chemiluminescence (ECL plus, Amersham Pharmacia
Biotech, Buckinghamshire, UK) or SuperSignalWest FemtoMaxi-
mumSensitivity Substrate (Thermo Scientiﬁc, Rockford, IL,USA)
and analyzed as before (Jiang et al., 2010).
LIPID PEROXIDATION ASSAY
The extent of LPO was determined using Lipid Peroxidation
Microplate Assay Kit (Oxford Biomedical Research), which
assesses the level of MDA derived from PUFA peroxides. Brieﬂy,
cells were thoroughly washed in ice-cold 20 mM phosphate-
buffered saline (PBS; pH 7.4), resuspended in PBS to obtain a
density of 5 × 107 cells per mL and followed by sonication in
the presence of 10 μL 0.5 M butylated hydroxytoluene per 1 mL
of cell suspension. Cell lysates were centrifuged at 3,000 × g and
4◦C for 10 min to remove large particles and then quantiﬁed for
protein concentration with Bicinchoninic acid Protein Assay Kit
(Pierce). For LPO determination, 140 μL of standards or samples,
455 μL of diluted Reagent R1 and 105 μL 37% hydrochloric acid
(HCl) were added into a microcentrifuge tube sequentially, mixed
and incubated at 45◦C for 60 min. The mixtures were then cen-
trifuged at 15,000 × g for 10 min to obtain a clear supernatant.
The supernatants were added into a microplate with a triplicate of
150 μL per well for each sample and read at 586 nm using Spectra
Max M4.
CELL VIABILITY
Cell viability was assessed usingCalceinAM(Invitrogen). Cultures
of 3D5/DAT cells grown in 24- or 48-well plates were incubated
with 2 μM Calcein AM in balanced salt solution for 30 min at
room temperature in the dark. Fluorescence signals emitted from
live cells by esterase-metabolized calcein weremeasured at 495 nm
(excitation)/530 nm (emission) using a Spectra Max M4 and Soft
Max Protein 4.6 software (Molecular Devices, Sunnyvale, CA,
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USA). All measurements were performed in triplicate from three
experiments.
IMMUNOCYTOCHEMISTRY
Cells grown on coverslips were rinsed with PBS, ﬁxed in 4%
paraformaldehyde (PFA) and permeabilized with 0.1 M Tris-
buffered saline (TBS, pH 7.6) containing 0.5% triton X-100 for
5 min. They were subsequently blocked with 3% goat serum
in TBS, incubated with antibody Synuclein-1 and DAT in TBS
containing 1% goat serum overnight at 4oC then incubated for
1 h with secondary antibodies of goat anti-mouse conjugated
with Alexa594 and goat anti-rabbit antibody conjugated with
Alexa488. Immunolabeled cells were stained with nuclei stain
4′,6-diamidino-2-phenylindole (DAPI; Invitrogen) for 10min and
evaluated by confocal ﬂuorescence microscopy (Zeiss LSM 510,
Carl Zeiss MicroImaging).
LYSOTRACKER LABELING OF LYSOSOMES
Differentiated cells with α-syn induction were cultured in Lab-Tek
Chambered Coverglass and subjected to different treatments for
certain time. At the end of treatment, LysoTracker Green DND-26
was added at a ﬁnal concentration of 100 nM to each well for 1 h.
Cells were then photographed by confocal microscopy. Fluores-
cence intensities from images in different groups were statistically
analyzed for evaluation of lysosomal function using Zen software.
STATISTICAL ANALYSIS
Data from at least three sets of independent experiments were
analyzed by one-way Anova with Dunnett’s post hoc test and Stu-
dent’s t-test for comparison of groups >3 and 2, respectively, for
statistical signiﬁcance.
RESULTS
EXPRESSION OF DOPAMINE TRANSPORTER IN 3D5/DAT CELLS
To verify that DAT transfected 3D5 cells express DAT, we com-
pared them with mock transfected counterparts by immunocy-
tochemistry (Figure 1A) and western blotting (Figure 1B). DAT
immunoreactivities were readily detected only in the DAT trans-
fected, whereas α-syn immunoreactivities were detected in both
DAT and mock transfected cells with Tet-Off induction. West-
ern blotting of cell lysates demonstrated robust signals of DAT
expression in the transfected and very weak signals in mock trans-
fected controls. It is worth noting that very low expression of DAT
in mock transfectant can be detected by western blotting but not
immunocytochemistrymight be due to the difference of sensitivity
between them.
TIME-DEPENDENT INCREASES OF LPO IN NON-INDUCED 3D5/DAT
CELLS WITH AA TREATMENT
To demonstrate the effects of AA on LPO we used non-induced
3D5/DAT cells (i.e., without α-syn overexpression) with 8 days
of RA-elicited neuronal differentiation, and treated them with
or without AA. In comparison to vehicle-treated cells (regarded
as controls), the AA-treated displayed a time-dependent increase
of MDA, a product of LPO. Signiﬁcant differences between the
AA-treated and controls were detected only after 48 h or longer
durations of treatment (Figure 2A). On overage, the amount of
MDA detected in cultures with 48, 60, and 72 h of AA exposure
was about 4, 19, and 40 times, respectively, of that present in their
counterparts without AA exposure for 72 h. Such increase of LPO,
however, did not have signiﬁcant impacts on cell viability upon the
AA exposure (Figure 2B), indicating that differentiated 3D5/DAT
cells without induced α-syn expression can tolerate a 3-day surge
of LPO.
LPO FACILITATES α-syn OLIGOMER ACCUMULATION AND CASPASE 3
ACTIVATION
To determine the effects of LPO on α-syn assembly, we used
3D5/DAT cells with induced α-syn expression. After treatment
with or without AA for up to 60 h these cells were analyzed by
LPO assay and western blotting. Similar to what was observed
in 3D5/DAT cells without α-syn induction, signiﬁcant increases
of LPO were detected in samples from cultures that have been
FIGURE 1 | Expression of dopamine transporter and α-syn in 3D5/DAT
cell line. 3D5 cells with DAT or mock transfection were maintained in
24-well plates containing coverglasses and 6-well plates and used for
(A) immunocytochemistry and (B) western blotting, respectively, after 8 days
of RA differentiation and α-syn induction. Dual immunoﬂuorescence labeling
demonstrated the expression both DAT (green) and α-syn (red) proteins in
transfected cells, whereas mock transfected displayed only α-syn
immunoreactivities. Nuclei of cultured cells were labeled by DAPI (blue).
Western blotting demonstrated the presence of more DAT in lysates prepared
from DAT transfected cells than those from mock transfected counterparts.
The levels of α-syn or GAPDH in lysates from the transfected and mock
transfected cells are comparable.
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FIGURE 2 |Time-dependent induction of LPO in RA-differentiated,
non-induced 3D5/DAT cells by AA treatment. 3D5/DAT cells with 8 days
of RA-elicited differentiation and without α-syn induction were treated with
AA for 12, 24, 36, 48, 60, and 72 h, referred to as AA-12h, AA-24h, AA-36h,
AA-48h, AA-60h, and AA-72h, respectively, or without for 0 and 72 h
(Con-0h, Con-72h). They were harvested and used for (A) LPO assay to
determine MDA levels per mg protein. (B) Sibling cultures of AA-72h and
Con-72h were used for Calcein AM assay to assess cell viability. Bar graphs
summarized data derived from three independent experiments using
different sets of cultures. The levels of LPO detected in cultures with 48,
60, and 72 h of AA exposure were 3, 19, and 40 times of that in Con72h
cultures, and the differences are statistically signiﬁcant. Error bars
represent standard errors of the mean (SEM). (*p < 0.05 and **p < 0.01
comparing to Con-0h, n = 3) In contrast to that displayed by LPO assay,
there was no signiﬁcant difference between cultures with and without 72 h
of AA exposure in regard to their viability.
exposed to AA for 48 h or longer durations. The extents of LPO
increase were comparable between the AA-treated cultures with
and without α-syn induction. However, more α-syn accumulation
were detected in cultures with AA treatment than without, and
more in those with longer durations of AA exposure (Figure 3A).
Such increase of α-syn accumulation was contributed not only by
increasing the level of monomeric α-syn but also that of different
sizes oligomericα-syn species (>33 kDa; Figures 3A–C).Wenoted
that cultures with 60 h of AA treatment contained far more large
sizes α-syn oligomers (>75 kDa) than those with shorter treat-
ment, and some of the large oligomers were too large to enter the
separation gel (Figures 3A,C). Moreover, small oligomers of size
consistent with that of α-syn dimer (∼30 kDa) were less abundant
in cultures with 60 h of AA exposure than those with shorter peri-
ods of treatment. Such shifting of α-syn gel electrophoretic proﬁles
indicates that the assembly of α-syn in these cultures is AA-elicited
and time-dependent. Besides α-syn accumulation, AA exposure
also resulted in increase of caspase 3 activation (Figures 3A,D)
and decrease of the viability of Tet-Off-induced cells (Figure 3E)
in a time-dependent manner.
To determine whether AA-elicited accumulation of α-syn
assembly is linked to LPO,we included cultures co-treatedwithAA
and TX or AA and TC in our studies of Tet-Off-induced 3D5/DAT
cells. TX is a potent water-soluble vitamin E analog that has been
used in numerous studies to block LPO by scavenging ROS before
they attack intracellular lipid (Wolf, 2005), and TC is a potent
inhibitor of long-chain fatty acyl CoA synthetase that can effec-
tively inhibit AA uptake and incorporation into cell (Hartman
et al., 1989). Our LPO assay showed that TX or TC co-treatment
protects cultures from AA-elicited LPO as expected. The level of
MDA in such co-treated cultures was about 28% of that in cul-
ture with AA treatment only (Figure 3F). Importantly, TX or TC
co-treatment was highly effective to reduce the effects of AA on
accumulation of oligomericα-syn species, caspase 3 activation and
cell death (Figures 3A–E).
Increases of monomeric α-syn and active caspase 3 levels were
also detected in non-induced 3D5/DAT cultures withAA exposure
(Figures 4A,D, compared S− to S−/AA). However, the extent is
much smaller than that demonstrated in cells with α-syn induc-
tion (Figures 4A,D, compared S−/AA to S+/AA). Importantly,
oligomeric α-syn was not detected in non-induced cultures with
AA exposure and the level of active caspase 3 is higher in their
induced counterparts (Figures 4A,C,D).
Together, our ﬁndings support the notion that LPO plays a role
in promoting α-syn accumulation/assembly in Tet-Off-induced
cells, that expression of certain levels of α-syn monomers can
facilitate the accumulation of large sizes α-syn oligomers and
that these events are associated with heightened caspase 3 acti-
vation.
α-syn EXPRESSION/ACCUMULATION INCREASES THE SENSITIVITY OF
CELLS TO AA-ELICITED CYTOTOXICITY IN AN α-syn
CONCENTRATION-DEPENDENT MANNER
To determine whether cytotoxicity caused by AA treatment is
linked to expression/accumulation of α-syn, we seeded RA-
differentiated 3D5/DAT cells in 48-well plate, induced the cultures
to express α-syn for 0, 2, 4, 6, or 8 days then exposed them
to AA for 60 h to initiate LPO. Cells in half of the plate were
harvested for western blotting analysis, and the rest were used
for calcein assay cell to evaluate cell viability. Western blotting
of cell lysates showed AA-treated cultures with longer durations
of Tet-Off induction having more α-syn accumulation and cas-
pase 3 activation than non-treated counterparts (Figures 5A–D).
In AA-treated cultures, signiﬁcant increase of monomeric α-syn
species was readily detected after 2 days of Tet-Off induction
(Figure 5B), whereas increase of oligomeric α-syn became appar-
ent after longer durations of induction (Figure 5C). Some
of such oligomers were greater than 250 kDa in size. Impor-
tantly, AA-treated cultures with longer durations of induced
α-syn expression displayed lower cell viability (Figure 5E), and
AA treatment of cultures without the induced α-syn expres-
sion had very little effects on cell viability (Figure 2B). Such
inverse relationship between the length of α-syn induction and
the magnitude of AA-elicited toxicity suggests that the sensitivity
of cells to insults increases in an α-syn concentration-dependent
manner.
DOPAMINE PROTECTS CELLS FROM TOXIC α-syn ACCUMULATION AND
REDUCES LPO ELICITED BY AA TREATMENT
It has been reported that presence of DA inhibits ﬁbrillization
of recombinant α-syn, and that such effect is exerted by oxida-
tive products of DA, which can covalently modify α-syn as well
as induce conformational change of α-syn to form SDS-resistant
soluble oligomers without having beta sheet structures (Cappai
et al., 2005). Based on this scenario, one would expect to ﬁnd
Frontiers in Cellular Neuroscience www.frontiersin.org May 2013 | Volume 7 | Article 81 | 4
“fncel-07-00081” — 2013/5/30 — 12:52 — page 5 — #5
Jiang et al. Dopamine prevents LPO-induced toxic alpha-synuclein.
FIGURE 3 | Facilitation of monomeric and oligomeric α-syn accumulation
and caspase activation by LPO. 3D5/DAT cells with 8 days of RA-elicited
differentiation andTet-Off induced α-syn expression were exposed to AA for
12, 24, 36, 48, and 60 h (regarded as AA-12h, AA-24h, AA-36h, AA-48h, and
AA-60h), treated with AA plus TX or AA plus TC in for 60 h (TX/AA-60h and
TC/AA-60h) or without any treatment for 0 or 60 h (Con-0h, Con 60h). Cells
harvested from each set of culture were split into two and used for western
blotting and LPO assay. Sibling cultures of con-60h, AA-60h, TX/AA-60h, and
TC/AA-60h were subjected to Calcein assay. (A)Western blotting of cell
lysates with antibodies to α-syn, active caspase 3 and GAPDH. (B–D) Bar
graphs represent data obtained from quantitation of immunoreactivities
displayed in (A) and western blot from two additional experiments. The levels
of immunoreactivity detected in controls (Con-0h) are regarded as 100%. Our
results showed more α-syn oligomers and active caspase 3 in cultures with
60 h of AA treatment, and such increase was reduced in cultures co-treated
with AA plus TX or TC. (E) Calcein assay of con-60h, AA-60h, TX/AA-60h, and
TC/AA-60h cultures. Results showed that AA-induced death can be blocked
signiﬁcantly by co-treatment with TX or TC. (F) LPO assay for all samples,
demonstrating a signiﬁcant increase of LPO levels after 48 h or longer
exposure of cultures to AA when compared to controls (compared AA-48 to
con-0h). Such changes were reduced signiﬁcantly by TX or TC co-treatment.
The results are representative of three independent experiments. Error bars
represent SEM. Number sign(s) marked signiﬁcant differences between two
groups linked by bracket (#p < 0.05, ##p < 0.01). Asterisk(s) indicated
signiﬁcant differences between the treated group and Con0h (*p < 0.05,
**p < 0.01).
more SDS-resistant α-syn assemblies in cultures withDA exposure
than without. To determine whether or not this is the case we
used differentiated, Tet-Off-induced 3D5/DAT cells, and treated
them with DA, without DA, or with DA plus AA. The concentra-
tion of DA used in most of this study was 50 μM, which is the
highest concentration regarded as physiological by others in pre-
vious studies (Grace and Bunney, 1983; Li et al., 2004; Heien et al.,
2005). Contrary to what was expected, cultures with DA expo-
sure contained less α-syn oligomers (about 33 kDa in size) than
those without (Figure 6A, compared DA to Con). Moreover, cells
with DA and AA co-exposure also accumulated signiﬁcantly less
α-syn than those treated with AA alone (Figures 6A,C, compared
DA/AA to AA), and most of the differences were due to decrease
of oligomeric α-syn species (Figures 6B,C, compared DA/AA
to AA).
In light of our ﬁndings regarding a close link between LPO
and α-syn self-interactions, we investigated whether DA treat-
ment can affect LPO levels. As shown in Figure 6G, samples
from cultures with DA plus AA treatment contained lower levels
of MDA than those treated with AA only, and the differences were
statistically signiﬁcant. DA treatment of cells without AA expo-
sure also caused some decrease of MDA levels when compared
to non-treated counterparts. However, this change is statistically
insigniﬁcant presumably because the extent of LPO was very low
to start with.
We next investigated whether reduction of α-syn accumulation
and LPO by DA treatment has any impacts on cell viability, since
it has been suggested that soluble oligomers may be cytotoxic. By
calcein assay we showed that DA exposure signiﬁcantly protects
cultures from the cytotoxic effects of AA treatment (Figure 6F).
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FIGURE 4 | Differential responses of cells with and without α-syn
induction to AA exposure. 3D5/DAT cells with 8 days of RA-elicited
differentiation plus Tet-Off induced α-syn expression and their non-induced
counterparts were treated with AA for 60 h and referred to as S+/AA and
S−/AA, sibling cultures without treatment were used as controls and referred
to as S+ and S−, respectively. (A)Western blotting of cell lysates with
antibodies to α-syn, LC3, active caspase 3, and GAPDH. (B–E) Bar graphs
represent data obtained from quantitation of immunoreactivities displayed in
(A) and western blot from two additional experiments. The results are
representative of three independent experiments. Error bars represent SEM.
Number sign(s) marked signiﬁcant differences between two groups
linked by bracket (#p < 0.05, ##p < 0.01). Asterisk(s) indicated signiﬁcant
differences between the treated group and Con0h (*p < 0.05, **p < 0.01).
Our results showed that S+/AA were demonstrated to accumulate
much more α-syn than S−/AA. Most of the increase of α-syn observed in
S−/AA is monomer, whereas that in S+/AA is oligomers and monomers.
The results of immunoblotting also showed that AA exposure heightened
the level of LC3-II and active caspase 3 in both S−/AA and S+/AA cultures,
but its impacts on caspase 3 was greater for the S+/AA than S−/AA
cultures.
Together our ﬁndings indicate that presence of DA canprotect cells
from accumulation of oligomeric α-syn, elevation of LPO and cell
death.
DA TREATMENT PROTECTS CELLS FROM AA-ELICITED α-syn
ACCUMULATION, LPO, AND CYTOTOXICITY VIA AUTOPHAGY
ACTIVATION
α-Syn accumulation
To determine how DA prevents cells from AA-elicited α-syn accu-
mulation, we tested whether autophagy plays a role, since it has
been reported that DA treatment can lead to increase of LC3-
II (Gimenez-Xavier et al., 2009). Western blotting of lysates of
Tet-Off-induced, differentiated 3D5/DAT cultures with antibod-
ies to proteins relevant to autophagy showed that DA treatment
causes increase of the ratio of LC3-II/GAPDH (Figure 6E) and
decrease the ratio of phosphorylated mTOR (p-mTOR)/total
mTOR levels, suggesting DA may function as an autophagy
inducer (Figures 6A,D,E, compared DA to Con).
Our studies of cells co-treated with DA plus AA as well as those
treated with AA alone also showed stronger signals of LC3-II acti-
vation, lower ratio of p-mTOR/total mTOR levels and less α-syn
accumulation in the co-treated, suggesting autophagy activation
may be a mechanism used by DA to prevent cells fromAA-elicited
α-syn accumulation (Figures 6A,D,E, compared lanes DA/AA and
AA). The role of autophagy in reducing α-syn accumulation was
supported further by data obtained from studying AA-treated cul-
tures co-treated with Rapa, which is an inducer of autophagy.
Cultures with Rapa and AA co-treatment accumulated less α-syn
oligomers than those treated with AA (Figures 6A,C, compared
Rapa/AA to AA).
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FIGURE 5 | Induced α-synuclein expression increases the sensitivity of
cells to AA-elicited cytotoxicity. Five sets of differentiated 3D5/DAT cells
with 0, 2, 4, 6, and 8 days of induced α-syn expression were exposed to AA
for 60 h and referred to as IN0d/AA, IN2d/AA, IN4d/AA, IN6d/AA, and
IN8d/AA, respectively. (A)Western blotting of lysates derived from these
cells with antibodies to α-syn, active caspase 3 as well as GAPDH showed a
time-dependent increase of monomeric and oligomeric α-syn species as well
as that of active form of caspase 3. (B–D) Bar graphs summarized
quantitative analysis of α-syn and active capase 3 immunoreactivities
displayed in (A) and normalized with GAPDH as well in western blot from
additional experiments. The average values of control groups (IN0d/AA) were
set as 100%. (E) Calcein assay showed an inverse relationship between cell
viability and the duration of α-syn induction in cultures with AA exposure.
Signiﬁcant decrease of cell viability was detected in cultures with 4 days or
longer durations of induced α-syn expression plus AA exposure when
compared to non-induced counterparts (IN0d/AA). The results are
representative of three independent experiments. Error bars represent SEM.
The changes of levels of various proteins or cell viability are statistically
signiﬁcant. (*p < 0.05, **p < 0.01 comparing to INd0/AA; #p < 0.05,
##p < 0.01, comparing subsets linked by bracket).
To further verify the role of autophagy in reducing α-syn
accumulation we compared cultures treated with DA to those co-
treated with DA plus AA or co-treated with DA, AA plus WM (an
autophagy inhibitor). Cultures withWMco-treatmentwere found
to accumulate more α-syn and p-mTOR/mTOR (Figures 6A,D,
compare DA to WM/DA or DA/AA to WM/DA/AA), but have
lower LC3-II/GAPDH ratio than those without the co-treatment
(Figure 6E). Together our data supports a role of autophagy in
reducing α-syn accumulation in DA-treated cultures.
Lipid peroxidation and cell viability
Besides α-syn accumulation, we have tested whether DA or Rapa
treatment can protect cells from the raise of LPO or decrease
of cell survival caused by AA exposure. We demonstrated that
AA-elicited LPO can be signiﬁcantly reduced by Rapa treatment
(Figure 6G, compared Rapa/AA to AA), and the extent of reduc-
tion is comparable to that observed in cells co-treated with DA
plus AA. Such beneﬁcial effects of DA on LPO were signiﬁcantly
blocked by WM treatment, albeit partially (Figure 6G, com-
pared WM/DA/AA to DA/AA). As to cell viability, Rapa was as
effective as DA in reducing the detrimental effects of AA on cell
survival (Figure 6F, compared DA/AA to AA). In comparison,
cultures treated with WM plus DA and AA were less viable than
those treated with DA plus AA. Together, these ﬁndings support
a role of autophagy in reducing the cytotoxicity elicited by AA
treatment.
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FIGURE 6 | Protection of cells fromAA-elicited α-syn accumulation, LPO,
and cytotoxicity by autophagy activation. Four sets of 3D5/DAT cells with
8 days of differentiation and α-syn induction were exposed for 60 h to AA, AA
plus Rapa, AA plus DA, AA plus DA andWM, and regarded as AA, Rapa/AA,
DA/AA, andWM/DA/AA, respectively. Additional four sibling cultures were
similarly treated but without AA and named as Con, Rapa, DA, andWM/DA.
Cells harvested from each subset were split into two parts for western
blotting and LPO assay. Duplicate cultures were included for cell viability
assessment. (A)Western blotting of lysates of all samples with antibodies
to α-syn, phosphorylated mTOR (p-mTOR), total mTOR, LC3, and GAPDH.
(B–E) Bar graphs summarized quantitative analysis of immunoreactivities
displayed in (A) with GAPDH normalization as well in western blot from
additional experiments. Results demonstrated that DA or Rapa treatment
decreases signiﬁcantly the relative amount of p-mTOR to mTOR and increase
that of LC3-II to GAPDH, suggesting an activation of autophagy or
accumulation of autophagosomes. These treatments also signiﬁcantly reduce
the level of AA-elicited α-syn oligomer accumulation. The effects of DA or
Rapa (data not shown) was blocked/reduced byWM co-treatment indicating
that autophagy inhibition counters the effects of DA on reducing α-syn
accumulation. (F) Calcein assay showed that Rapa treatment is as effective as
DA in protecting cells from AA-elicited cytotoxicity, and thatWM co-treatment
reduces the beneﬁcial effects of DA on cell viability. (G) LPO assay showed
that Rapa treatment is as effective as DA in lowering LPO, and thatWM
co-treatment can reduce the impact of DA on LPO. (*p < 0.05, **p < 0.01
comparing to Con; #p < 0.05, ##p < 0.01, comparing subsets linked by
bracket). Error bars represent SEM.
AA TREATMENT-INDUCED ACCUMULATION OF LC3-II AND LYSOSOMAL
DYSFUNCTION
It is worth noting that cells treated with AA, regardless of whether
they have α-syn induction or not, have a signiﬁcantly higher LC3-
II/GAPDH ratio than non-treated control. We speculated that the
changes of LC3-II/GAPDHratiomay reﬂect decrease of autophagy
ﬂux via disturbance of lysosomes, since the treated cells have
more α-syn accumulation (i.e., monomers in non-induced and
monomers plus oligomers in induced), and α-syn can be degraded
by lysosomal proteases (Lee et al., 2004; Sevlever et al., 2008; Mak
et al., 2010). Moreover, studies of lysosomes isolated from liver
have demonstrated that AA treatment can alter lysosomal per-
meability to both potassium ions and protons and enhance the
lysosomal osmotic sensitivity (Zhang et al., 2006).
To study the effects of AAon lysosomes,we incubated 3D5/DAT
cells with LysoTracker Green DND-26, which is a ﬂuorescence
agent that stains acidic compartments in live cells (Figure 7A).
We compared the intensities of ﬂuorescence signals emitted from
cells treated with AA to those without. Cells with α-syn induction
and treated with AA for 60 h were found to display signiﬁcantly
weaker ﬂuorescence signals than those without (Con) or treated
with only Rapa,WM or DA at 50 μM (Figures 7A,B) and 500 μM
(data not shown). The results support that AA treatment causes
an increase of lysosomal membrane permeability, and that such
change is probably responsible for increase of α-syn accumulation
in α-syn-induced cells. Similar results were obtained from Lyso-
Tracker labeling of non-induced cells (data not shown). In order to
further understand how treatment with DA at physiological con-
centration protects cells from AA-elicited changes, we compared
cells with DA and AA co-treatment (50DA/AA) and those with
AA treatment alone (AA) for LysoTracker staining. Cultures with
50DA/AA were found to display stronger ﬂorescence signals than
AA (Figures 7A,B, 50DA/AA versus AA). The differences are sta-
tistically signiﬁcant. Importantly, the co-treated were comparable
to untreated controls as to ﬂuorescence signal intensity (Figure 7,
50DA/AA versus Con), indicating prevention of lysosomal dam-
ages is a mean for protection of AA-elicited damages. LysoTracker
staining showed a signiﬁcant decrease of ﬂuorescence signals in
cell treated with AA plus>100 μM when compared to controls or
those treated with AA plus 50 μM DA (Figures 7A,B).
BIPHASIC EFFECTS OF DA EXPOSURE ON α-syn OLIGOMER
ACCUMULATION AND CELL SURVIVAL
It has been reported that autophagy pathway is capable of killing
cells (Jaeger andWyss-Coray,2009; Choubey et al., 2011). Todeter-
mine whether DA at concentration higher than 50 μM can still
protect Tet-Off-induced 3D5/DAT cultures from AA-elicited tox-
icity and α-syn accumulation, we compared cultures treated for
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FIGURE 7 | AA treatment induces lysosome dysfunction in 3D5/DAT
cells. Eight sets of 3D5/DAT cells cultured on Lab-Tek Chambered
Coverglass were subjected to 8 days of differentiation and α-syn induction.
They were treated for 60 h with Rapa, DA (50, 100, or 500 μM),WM, AA, or
without any treatment to serve as control (Con). At the end of treatment,
LysoTracker Green (invitrogen) was added at a ﬁnal concentration of
100 nM to each well for 1 h. Cells were then evaluated for lysosomal
function by confocal microscopy. (A) Representative images of LysoTracker
labeled cells in different groups were shown. (B) Bar graph summarized
data from quantitative and statistical analyses of more than 20 images
captured from each group. (*p < 0.05, **p < 0.01 comparing to Con;
##p < 0.01, comparing subsets linked by bracket).
60 h with AA plus DA at different concentrations, ranging from
0 to 500 μM. Western blotting of lysates from these cells showed
accumulation of lower levels of α-syn in those co-treated with AA
plus 25 or 50 μM DA than cultures treated with AA only (i.e., AA,
Figures 8A,B and C). By contrast cultures co-treated with AA and
DA at 300 μM or higher concentrations accumulated more α-syn
than those treated with AA alone. Such biphasic effects of DA did
not apply to autophagy markers as the ratio of p-mTOR/mTOR
and LC3-II/GAPDH changed in a DA concentration-dependent
manner (Figures 8A,D,E). Cultures treated with AA and DA at
300 μM or higher concentrations contained more active cas-
pase 3 and were less viable than those with AA treatment only
(Figures 8A,F,G, compared 300DA/AA to 50DA/AA), while those
treated with AA and DA at lower than 300 μM showed less cas-
pase 3 activation than the AA-treated. Thus, depending on its
concentration, the presence of DA can have opposite effects on
neuronal cell survival and α-syn accumulation. This is consistent
with previous reports that autophagy pathway can be involved in
both survival and death of cells (Cherra and Chu, 2008; Jaeger and
Wyss-Coray, 2009).
Next, we examined cultures exposed to AA plus DA at differ-
ent concentrations upon LysoTracker labeling (Figures 7A,B). In
contrast to what was demonstrated in 50 μM DA plus AA-treated
cells, those co-treated with DA at higher concentrations displayed
signiﬁcantly weaker ﬂuorescent signals than controls. Fluoresce
signals displayed by cultures co-treated with 50 or 100 μM DA
and AA are signiﬁcantly more intense than those detected in those
co-treated with 500 μM DA and AA. Moreover, the 500 μM DA
co-treated tend to show weaker lysosomal staining than
those treated with AA only, although statistically insigniﬁ-
cant(Figures 7A,B).
DISCUSSIONS
Information accumulated fromnumerous studies suggests that PD
is associated with perturbation of multiple pathways to result in
abnormal energy metabolism, oxidative and ER stresses, increase
of α-syn aggregation, synaptic dysfunction, and other damages
(Jenner,1991; FahnandCohen,1992; SimonandBeal,2002;Dauer
and Przedborski, 2003; Picconi et al., 2012). Many of the changes
were detected in brain tissue of subjects at early stages of PD (Braak
et al., 2003). Although it remains uncertain if a certain pathwaywas
affected before others, it is reasonably to consider that abnormali-
ties displayed at different stages of PD likely reﬂect the cross-talks
amongdifferent pathways. Oxidative stress has beenplaced as a key
component in PD pathogenesis (Jenner, 1991; Fahn and Cohen,
1992; Tieu et al., 2003), since it is known to link ROS production
to a variety of metabolic outcomes, including oxidative modi-
ﬁcation of proteins and lipids (Danielson and Andersen, 2008;
Radak et al., 2011), which in brain tissue are enriched in PUFAs
(Rapoport, 2008; Whelan, 2008). Polyunsaturated acyl chains of
phospholipids or PUFAs such as AA, docosahexaenoic acid, and
linoleic acid are highly susceptible to peroxidation and break-
down to form a variety of lipid-derived aldehydes and ketones
(Frankel, 1984). In this regard, it has been reported that at very
early stages of PD (stages 1 and 2), before the appearance of α-syn
aggregates, neurons in substantia nigra display signs of oxidative
damage to lipid, and this brain region at stage 3 displays punc-
tate aggregates containing α-syn modiﬁed by oxidization among
other types of posttranslational modiﬁcations (Ferrer et al., 2011).
In vitro studies have shown that modiﬁcation of α-syn by LPO
products (e.g., 4-hydroxynonenal) leads to inhibition of α-syn ﬁb-
rillization and formation of soluble oligomers (Qin et al., 2007).
Addition of 4-hydroxynonenal modiﬁed α-syn oligomers to neu-
ronal cell cultures caused cell death, suggesting the oligomers
are cytotoxic (Qin et al., 2007). It has long been considered that
a signiﬁcant contributing factor rendering dopaminergic neu-
rons more susceptible to degeneration than other neurons is the
high susceptibility of DA to undergo autoxidation (Miyazaki and
Asanuma, 2008). Cell-based studies have shown that increase
the steady-state levels of DA can inhibit formation of α-syn
aggregates and induce the formation of innocuous oligomers
(Yamakawa et al., 2010) and exposure to DA at non-physiological
concentrations caused cell death (Gomez-Santos et al., 2003;
Benchoua et al., 2008).
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FIGURE 8 | Biphasic effects of DA exposure on α-syn oligomer
accumulation and cell survival. 3D5/DAT cells seeded on 48-well
plates with 8 days of differentiation and α-syn induction were exposed
to AA plus 0, 25, 50, 100, 300, or 500 μM DA for 60 h and referred
to as AA, 25DA/AA, 50DA/AA, 100DA/AA, 300DA/AA, 500DA/AA,
respectively. They were used for western blotting with antibodies
raised to α-syn, p-mTOR, mTOR, LC3, active caspase 3, and GAPDH
and for calcein assay. (A)Western blotting of cell lysates with antibodies
to α-syn, p-mTOR, mTOR, LC3, active caspase 3, and GAPDH. (B–F) Bar
graphs summarized data from quantitation of the immunoreactivities of
various proteins labeled in (A) with GAPDH normalization and that from
additional experiments. Results showed that co-treatment of cultures
with 25 or 50 μM DA plus AA (regarded as 25DA/AA, and 50DA/AA)
caused decrease of both oligomeric α-syn accumulation and active
caspase 3 levels, but similar co-treatment with 300 or 500 μM DA plus
AA led to increase of these parameters above the levels demonstrated in
cells with AA exposure only. By contrast, the relative level of autophagy
markers (i.e., p-mTOR/mTOR and LC3-II/GAPDH) changed in a DA
concentration-dependent manner. (G) DA at 50 μM or lower concentrations
signiﬁcantly protected cultures from the detrimental impacts of AA exposure
on cell viability, whereas at higher concentrations (>300 μM) the presence of
DA caused a signiﬁcant reduction of cell viability (*p < 0.05, **p < 0.01
comparing to AA; #p < 0.05, ##p < 0.01, comparing subsets linked by
bracket).
To understand further the role of lipid oxidation, DA and α-
syn and their interactions in PD, we performed a series of studies
using cultured cells of human origin generated in present studies.
The cells, regarded as 3D5/DAT, are inducible to express human
wild-type α-syn and express DAT stably. They displayed neu-
ronal phenotype in response to RA treatment (Ko et al., 2008). We
employed AA exposure as a mean to promote LPO in these cells
and have demonstrated that themagnitude of LPO is AA exposure
time- (Figures 2 and 3) and concentration-dependent as reported
previously (Canuto et al., 1991; Schonberg et al., 2006). In our cul-
tures, a minimum 2 days of exposure to 250 μM AA was required
to cause a signiﬁcant elevation of LPO levels (Figure 2A), and
longer durations of exposure were required to achieve the same
effect if lowerAA concentrations were used (data not shown). This
is due to the fact that LPO is a free radical-mediated chain reac-
tion, involving initiation, propagation, and termination (Young
andMcEneny, 2001; Farooqui and Farooqui, 2011) and that prod-
ucts of LPO are highly reactive to make covalent modiﬁcations of
macromolecules (Grimsrud et al., 2008; Gueraud et al., 2010).
Although it has been reported that overexpression of α-syn
can increase intracellular ROS levels (Junn and Mouradian, 2002)
in other cell types, our previous studies have shown that the
level of ROS in 3D5 cells is not signiﬁcantly affected by α-syn
overexpression (Takahashi et al., 2007). In fact, during the course
of AA treatment (i.e., up to 72 h), cells with α-syn induction
displayed LPO at the extent comparable to that detected in cor-
responding samples without the induction. Therefore, that α-syn
overexpression has no inﬂuence on LPO in present study. We also
demonstrated that AA exposure can cause caspase 3 activation
as reported previously (Vento et al., 2000; Saitoh et al., 2003). The
increase of active caspase 3 byAA treatment is time-dependent and
the pattern of changes parallels that of AA-elicited LPO, show-
ing marked and sustained elevation in cultures treated for 60 h
or longer. Moreover, cells with α-syn induction contained more
active caspase 3 and exhibited less viability than their non-induced
counterparts. The changes of caspase activation and cell viability
probably are linked to LPO, since they were signiﬁcantly reduced
in cells co-treated either with AA plus LPO scavenger (TX) or
AA plus its uptake inhibitor (TC; Figure 3). It is worth noting
that cells expressing more α-syn are more responsive to activation
of caspase 3 and to decrease of viability elicited by AA exposure,
which is consistent with previous studies that α-syn overexpres-
sion increases the sensitivity of neuronal cells to different insults
(Orth et al., 2003; Nieto et al., 2006; Bisaglia et al., 2010; Jiang et al.,
2010, 2013). However, themechanismunderlying thatα-synmod-
ulates the level of active caspase 3 inAA-treated cultures is unclear.
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Since the increase of active caspase 3 is concomitant with that of
LPO and oligomeric α-syn, it is possible that in present study LPO
induced α-syn oligomers have α-syn dose-dependent toxicity, thus
trigger the activation of caspase 3 in a stronger manner than LPO
alone, and render cells bearing more α-syn more vulnerable to
LPO insults. The exact mechanism remains further investigations.
Another consequence of AA exposure to cells with α-syn induc-
tion is enhanced accumulation of α-syn monomers and different
sizes oligomers. Such responses were also detected in cells without
the induction, but themagnitude ismuch smaller andmore appar-
ent for monomers (Figure 4). The AA-elicited α-syn oligomers
are detectable by SDS-PAGE, hence are deemed as SDS-resistant.
Accumulation of these oligomers are results of either acceleration
of α-syn assembly and/or decrease of its degradation. The latter
possibility was tested by examining the levels of LC3-II/GAPDH,
p-mTOR versus total mTOR, and the integrity of lysosome mem-
branes. Although western blot studies showed that AA treatment
affects the ratio of LC3-II/GAPDH and that of p-mTOR/total
mTOR, these changes do not guarantee autophagic degradation,
since protein degradation via autophagy-lysosome system requires
fusion of autophagosomes to functional lysosomes. LysoTracker
labeling of 3D5/DAT cells demonstrated that the integrity of lyso-
somes was compromised by AA treatment (Figure 7). Therefore,
AA-elicited α-syn accumulation is a result of decreased pro-
tein degradation and changes of autophagy markers detected in
the AA-treated cells reﬂects likely the inhibition of autophagic
degradation of LC3-II (i.e., accumulation of autophagosomes).
We have demonstrated that addition of DA at physiological
concentrations to AA-treated 3D5/DAT cells leads to not only a
marked decrease of oligomeric α-syn, decrease of LPO and active
caspase 3, but also increase of cell viability. Opposite results were
obtained from similar analysis of cells with exposure to DA at
higher concentration. Together the results indicate that DA treat-
ment has biphasic effects; pro and against cell survival at low
and high concentrations, respectively. How DA exerts the oppo-
site effects observed in our studies is an issue of interest. We
explored the possibility that at low concentrations DA treatment
may activate autophagy to degrade α-syn and other proteins sus-
ceptible to modiﬁcation by LPO products, some which can be
cytotoxic (Camandola et al., 2000). This is supported by data from
studies of cells with or without co-treatment with Rapa or WM
(Figure 6). Rapa exposure has the same impacts as low DA on
blocking the changes elicited by AA, whereasWM exposure coun-
tered the impacts of DA. Similar to what was demonstrated in the
AA-treated, cells with exposure to DA alone or DA plus AA have a
higher ratio of LC3-II/GAPDH and lower ratio of p-mTOR/total
mTOR than controls. However, it was revealed by LysoTracker
labeling that those treated with 50 μM DA, or 50 μM DA plus
AA are comparable to untreated controls or those treated with
Rapa or WM in respect to lysosome integrity, suggesting that at
low concentration DA can protect cells from AA-induced cyto-
toxicity by maintaining normal lysosomal functions. It is worth
noting that increase the steady-state levels of DA via overexpres-
sion of tyrosine hydroxylase has been shown to inhibit formation
of α-syn aggregates in SH-SY5Y cells overexpressing A53T mutant
or wild-type α-syn without causing additional cell death (Mazzulli
et al., 2006).
A previous study had exposed rat primary embryonic striatal
neurons to different concentration of DA (100, 200, 300, 400,
500μM) and found that only those exposing tomore than 200μM
DA showed loss of cell viability (Benchoua et al., 2008). Later,
another study showed that exposure of SH-SY5Y cells to 100 or
500 μM DA resulted in a DA dose-dependent increase of LC3-
II, and cell death occurred only in 500 μM DA (Gimenez-Xavier
et al., 2009). Consistent with those studies, our results also showed
DA dose-dependent increase of LC3-II and that only high con-
centrations of DA (>300 μM) cause decrease of viability in cells
co-exposed to AA. The association between LC3-II increase, pro-
tein clearance and cell apoptosis is an issue of interest. As we
discussed earlier, and reported previously by others (Mizushima
and Yoshimori, 2007), increase of LC3-II/LC3-I alone are not
sufﬁcient to support whether autophagy activation leading to suc-
cessful clearance of proteins/subcellular organelles has occurred or
not. Based on our LysoTracker labeling, DA at high concentrations
could not protect cells from AA-elicited damages of lysosomal
membranes but exacerbate the damage to some extent. Thus, it
is reasonable to consider that enhanced α-syn accumulation and
reduced cell viability observed in our cultures exposing to high
concentration of DA plus AA are due to further blockage of lyso-
somal degradation of α-syn andother proteins. However,we noted
that cells treated with high concentrations of DA alone were com-
parable to those treated with low DA with respect to LysoTracker
labeling intensity and cathepsin D activities (unpublished data).
Therefore, additional mechanisms are likely involved in caspase
activation/cell death heightened by treatment of cells to AA plus
high concentration of DA.
Exposure to DA at high concentrations has previously been
reported to cause (i) impairment of proteasomes, (ii) increase
in hypoxia-inducible factor 1 alpha, (HIF-1) (iii) accumulation
of ubiquitinated proteins and proteins regulated by HIF-1 alpha
and involved in apoptosis and/or autophagy (e.g., p53, Puma
and Bnip3; Keller et al., 2000; Gomez-Santos et al., 2003; Ben-
choua et al., 2008; Gimenez-Xavier et al., 2009). Abnormal protein
accumulation, in turn, can affect cell survival via activation of cas-
pases to result in apoptotic/autophagic cell death (Qiu et al., 2000;
Gomez-Santos et al., 2003). This is supported by our ﬁndings of
increased levels of active caspase 3 cells treated with high concen-
trations of DA and decrease of this form of caspase in those treated
with low concentrations of DA. We do not know what mech-
anisms are involved to maintain lysosomal membrane integrity
upon exposure to low concentrations of DA. This issue will be
pursued in future investigation.
Besides preserving lysosome membrane integrity, low con-
centration of DA may protect AA-elicited cytotoxicity via other
mechanisms. In this regard it has been reported that bind-
ing of agonists to D2/D3 receptors can lead to induction of
bcl2 and suppression of cytochrome c release from mitochon-
dria (Kihara et al., 2002; Park et al., 2011). However, in our cell
model, the possibility of this pathway playing a signiﬁcant role
in protecting cells from AA toxicity by low concentration of DA
is low. This is in view of the results obtained from our recent
studies, in which an additional transfectant derived from 3D5
cells (i.e., 3D5 cells transfected with pVgRXR and pIND-DAT
sequentially) was used. Expression of α-syn and DAT in this new
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transfectant is inducible by removing tetracycline and adding
muristerone, respectively. This transfectant differs from 3D5/DAT,
which expresses α-syn and DAT with and without induction,
respectively. We found that upon induction of α-syn and DAT
expression this new transfectant responded to AA and low con-
centration of DA in a manner comparable to that of 3D5/DAT
cells. We also found that in the absence of induced DAT expres-
sion the presence of low DA offered no protective effects on AA
toxicity. These ﬁndings suggest that DA uptake via DAT rather
than its binding to D2/D3 receptors is critical for DA’s protective
effects.
Regardless, our results support the possibility that physiological
levels of DA has role in maintaining autophagy-lysosomal func-
tion. It is worth noting that Rapa has been reported to protect
against neuronal death in PD animal models generated from
treatment with neurotoxins such MPTP (1-methyl-4-phenyl-
1,2,3,6-tetrahydropyridine) and 6-OHDA (6-hydroxydopamine),
and to prevent L-DOPA (L-3,4-dihydroxyphenylalanine)-induced
dyskinesia in 6-OHDA lesioned animals (Malagelada et al.,
2010; Feyder et al., 2011). Together with the ﬁndings from
our cell-based studies, highlight the potential of mTOR sig-
naling cascade as a promising target for development of PD
therapeutics.
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